Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Matchpoint Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Matchpoint Therapeutics

Matchpoint Therapeutics

Matchpoint: A biotech firm innovating precision covalent medicines for immune diseases via ACE platform.

HQ
Cambridge, MA, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Matchpoint Therapeutics, founded with the mission to revolutionize the treatment of immune diseases and other serious illnesses, focuses on the development of precision covalent medicines. Utilizing their proprietary Advanced Covalent Exploration (ACE) platform, Matchpoint integrates advanced chemoproteomics and machine learning to discover and develop innovative therapies. The company's primary market focus is on immune system diseases, leveraging their expertise to create targeted and effective treatments.

Notable investors in Matchpoint Therapeutics include Sanofi, which has backed the company with a $100 million investment. This significant funding underscores the confidence in Matchpoint's potential to impact the biotechnology sector. Key achievements include the successful launch of their ACE platform and securing substantial financial support to advance their research and development efforts. Matchpoint's innovative approach has positioned it as a promising player in the biotech industry, with the potential to make a significant impact on the treatment of immune diseases.

Matchpoint Therapeutics - Similar Companies

Metaphore Biotechnologies logo

Metaphore Biotechnologies

metaphorebio.com

Faze Medicines logo

Faze Medicines

fazemed.com

Nested Therapeutics logo

Nested Therapeutics

nestedtx.com

ProFound Therapeutics logo

ProFound Therapeutics

profoundtx.com

Ampersand Biomedicines logo

Ampersand Biomedicines

ampersand.bio

Adcentrx Therapeutics logo

Adcentrx Therapeutics

adcentrx.com

Frontier Medicines logo

Frontier Medicines

frontiermeds.com

Endpoint Health logo

Endpoint Health

MolecularMatch logo

MolecularMatch

molecularmatch.com

Montai Health logo

Montai Health

montai.com

Enavate Sciences logo

Enavate Sciences

Marlinspike Therapeutics logo

Marlinspike Therapeutics

Dewpoint Therapeutics logo

Dewpoint Therapeutics

dewpointx.com

NextPoint Therapeutics logo

NextPoint Therapeutics

nextpointtx.com

Celsius Therapeutics logo

Celsius Therapeutics

celsiustx.com

Matchpoint Therapeutics - Quick Facts

Who are Matchpoint Therapeutics' competitors?

Companies similar to Matchpoint Therapeutics include Metaphore Biotechnologies, Faze Medicines, Nested Therapeutics and ProFound Therapeutics.

When was Matchpoint Therapeutics founded?

Matchpoint Therapeutics was founded in 2021.

Where is Matchpoint Therapeutics' headquarters located?

Matchpoint Therapeutics' headquarters is located in Cambridge, MA, US.

When was Matchpoint Therapeutics' last funding round?

Matchpoint Therapeutics' most recent funding round was for $70M (USD) in October 2022.

How much has Matchpoint Therapeutics raised to-date?

As of Oct 14, 2022, Matchpoint Therapeutics has raised a total of $100M (USD).

How many employees does Matchpoint Therapeutics have?

Matchpoint Therapeutics has 28 employees as of Feb 5, 2024.

Matchpoint Therapeutics - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medicines
  • Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified